a novel optical-based high-throughput screening technology has been developed for increasing the rate of discovering chemical leads against rna targets. scan  (Screen for Compounds with Affinity for Nucleic acids) is an affinity-based assay that identifies small molecules that bind and recognize structured rna elements. this technology provides the opportunity to conduct high-throughput screening of a new class of targets-rna. scan  offers many attractive features including a simple homogeneous format, low screening costs, and the ability to use common laboratory equipment. a scan  assay was developed for the hcV ires loop iiid rna domain. a high-throughput screen of our entire compound library resulted in the identification of small molecule ligands that bind to loop iiid. the Z′ values were greater than 0.8, showing this to be a robust high-throughput screening assay. a correlation between scan  ec 50 and K D values is reported suggesting the ability to use the assay for compound optimization. (Journal of Biomolecular Screening 2009:219-229) 
INTRODUCTION
R na is the genetic material of pathogenic viruses such as hepatitis c (hcV) and provides numerous opportunities for the discovery of new drug therapeutics. a characteristic feature of rna is that it can fold into complex secondary and compact tertiary structures 1,2 with defined and adaptive regions for intermolecular interactions. these complex folds provide rich and structurally diverse possibilities for developing specific small molecule rna therapeutics. in fact, several drugs targeting bacterial ribosomal rna have been in clinical use for more than half a century providing a proof-of-principle that rna can function as a drug target. [3] [4] [5] several of the antibiotics approved for drug use have been shown to selectively bind bacterial ribosomal rna folded regions with nanomolar affinity. [6] [7] [8] it is anticipated that viral rnas can be targeted in a similar way.
the hcV genome contains a highly conserved internal ribosome entry site (ires) located within the 5′-nontranslated region (5′ntr) that is responsible for directing cap-independent translation of the viral polyprotein. 9-12 the ires contains two major secondary structural regions, domains ii and iii, [13] [14] [15] [16] that are essential for viral replication. 13 in particular, single point mutations within subdomain iiid have shown that loop iiid is involved with ires folding, binding of the 40s ribosomal subunit to the ires, and is critical for hcV ires mediated translation. 17, 18 the point mutation studies suggest that small changes in the ires structure can have a profound effect on translation indicating that small molecule binding to these sites may also have a major impact on biological activity. loop iiid is highly conserved, with the six-nucleotide hairpin loop (UUgggU) being absolutely conserved across all hcV genotypes. 11, 12 the structure of loop iiid was one of the first ires domains to be solved by nmr spectroscopy and it showed that the rna fragment forms a stable helical stem with a disordered hairpin loop. 17, 19 the development of small molecule therapeutics for rna targets requires general approaches for detecting and quantifying rna-small molecule interactions that can be employed in high-throughput screens. the classes of compounds that bind rna with specificity are continuing to be elucidated as more rna and rna-small molecule structures are solved by x-ray crystallography and nmr spectroscopy. 20, 21 Without extensive knowledge of rna-ligand interactions to enable the use of computational methods to identify leads, rapidly screening large compound libraries is essential to help determine what constitutes a good rna binder for specific targets. several systematic screens have been conducted against fragments of hiV-1 rna. high-affinity hits were identified; however, in all cases they were strongly cationic. [22] [23] [24] the rna ligand affinities were dominated by electrostatic interactions and consequently selectivity was poor. attempts to identify new classes of compounds using high-throughput screening against rna targets has produced active compounds at a much lower rate than observed for protein targets. 25 the low hit rate from the high-throughput screens has been attributed to the difficulty in detecting and accurately measuring low-affinity interactions between small molecules and rna. 26 there is consequently a strong need to develop screening methodologies that have increased throughput, can detect low-affinity interactions, and are capable of assessing specificity to the rna target.
traditional methods used for detecting nucleic acid ligand binding interactions such as gel electrophoresis, ultrafiltration, or the original version of scan  , 27 a heterogeneous filter binding assay that used radioactivity as the detection method, lack the throughput, reliability, and sensitivity needed for highthroughput screening. current binding assays that have been developed based on surface plasmon resonance (sPr), 28 fluorescence spectroscopy, 29 and electrospray ionization mass spectroscopy 30 have the general shortcomings of either not meeting the necessary throughput or require expensive and complex instrumentation to operate. many of the fluorescence methods cited are complicated by the need to label the small molecule with a fluorophore or depend on changes in the local environment of the fluorophore. these approaches are more appropriate for a research level of studying binding interactions than for high-throughput screening.
scan  (Screen for Compounds with Affinity for Nucleic acids) is a novel, affinity-based high-throughput screening assay that identifies compounds that bind rna using an optical detection method. scan  offers the following advantages: 1) high throughput: it can screen large chemical libraries in a short time period, a necessity for identifying compounds against targets with traditionally low hit rates; 2) sensitivity: it is capable of reliably and accurately measuring binding interactions that cover a broad affinity range (nm to high µm); 3) inexpensive: the assay uses standard laboratory equipment and reagents are estimated to cost $0.05 per well; 4) flexibility: the assay can potentially be formatted for any structured rna target and can readily be used to screen large chemical libraries or a small scale structural analog series; 5) homogeneous: this assay format offers a rapid mix and read; and 6) optical detection: an optical-based assay format eliminates the use of radioactive isotopes. this report describes the development and application of a high-throughput, 384-well scan  assay and its full automation using standard robotic equipment. this assay demonstrates high quality, robustness, and reproducibility and has been successfully used to screen anadys' compound library and identify small molecules that bind to the hcV ires loop iiid rna fragment.
MATERIALS AND METHODS

Reagents
Biotin, cy3-and cy5-labeled rna, and Dna oligos were synthesized and Page purified by trilink Biotechnologies (san Diego, ca). the purity of the oligos was confirmed by Page analysis. tris and hepes buffer, ethanol, formamide, bromophenol blue, temeD, ammonium persulfate, potassium chloride, magnesium chloride, ammonium sulfate, sodium acetate, spermidine, triton X-100, dithiothreitol, DmsO, urea, and t7 rna polymerase were obtained from sigma aldrich (st. louis, mO). Ultrapure ntPs (atP, ctP, gtP, and UtP) were also ordered from sigma aldrich. Polyacrylamide 40%, 19:1 Bis solution was purchased from Bio-rad life science research (hercules, ca). all compounds screened were either from our compound library or synthesized in-house.
RNA construct synthesis
the t7 promoter (5′-taa tac gac tca cta at-3′) and Dna oligos that encode loop iiid (5′-gcc ttt cgc gac cca aca cta ctc ggc tat agt gag tcg tat ta-3′) were purchased from Qiagen Operon (alameda, ca). milligram quantities of loop iiid rna for direct binding studies by isothermal calorimetry (itc) were synthesized using standard in vitro transcription procedures on a large scale. the transcribed rna was purified by denaturing Page. the desired rna band was cut from the gel and the rna extracted by the crush-and-soak method. the purity of the rna was confirmed by Page analysis.
SCAN  assay
the assay was performed in white 384-well Pcr plates from abgene. a total of 5 µl of 4× compound (25 µm in 2.5% DmsO [final]) was mixed with 5 µl of 4× buffer/salt mix (50 mm hepes ph 7.5, 100 mm Kcl, 3 mm mgcl 2 , 0.05% tween 20 [final]). a total of 10 µl of a 2× rna/Dna mixture was added (rna annealed in 5 mm Kcl, 5 mm hepes ph 7.5; 100 nm rna/110 nm Dna [final]) and the reaction was incubated for 45 min before reading. the final buffer conditions for the 20 µl of mixture were 50 mm hepes ph 7.5, 100mm Kcl, 3 mm mgcl 2 , and 0.05% tween 20. a customized automated robotic system was used for dispensing reagents into 384-well plates using a matrix Platemate 2×2 (thermo Fisher scientific, hudson, nh) and loading the plates into the Victor V plate reader (Perkinelmer, ma). the scan  assay, as a 384-well format coupled with the robotic system, allowed for screening ~60,000 compounds in a 24-h period. the throughput can be increased by adding additional plate readers. the plates were read at two emission wavelengths with a Victor V plate reader. an excitation filter of 535 nm was used to excite cy3 and emission wavelengths of 590 nm (cy3) and 670 nm (cy5) were measured. the fluorescence resonance energy transfer (Fret) signal was calculated from the raw cy5/cy3 signals according to the following equation:
Fret signal = 1000 * (counts at 670 nm/counts at 590 nm). monitoring the ratio of the Fret signal offers greater sensitivity and better signal-to-noise; therefore, it was the detection method utilized in the high-throughput screen.
columns for high and low controls were added to each plate to enable determination of the %inhibition of compound binding to rna in the rna-Dna hybridization reaction. the %inhibition of hybridization was calculated using the following equation:
where the high control is the reaction mixture in the absence of compound and the low control has replaced the cy5-labeled Dna oligo with free cy5 dye, also in the absence of compound. the high control, low control, and sample inputs were determined from the ratio of the Fret signal as described above.
to assess assay quality, robustness, and reproducibility, the statistical calculation for the Z′ factor was used. the Z′ factor was calculated using the following formula:
where sD is the standard deviation. a Z′ factor of 1 is a perfect assay, and ≥0.5 indicates a good assay.
Choice of FRET pair
assays utilizing fluorescence resonance energy transfer detection provide a robust system for high-throughput screening. For the scan  assay, the rna was labeled with cy3 and the Dna capture oligo with cy5. the cy3/cy5 Fret pair provides a red-shifted absorption (cy3/cy5 abs max = 550/650 nm) and emission maximum (cy3/cy5 em max = 570/670 nm) that reduces the false positives from compound fluorescence. in addition, a Förster radius (r 0 ) of 55 Å provided a suitable distance dependence for the current assay design. energy transfer only occurs when the spectra of the donor emission and acceptor excitation overlap, and the Fret pair is in close proximity, a distance defined by the Förster radius. Fluorescent modification of custom synthesized oligonucleotides with cy3/cy5 dyes was also readily available from commercial venders.
Kinetics of hybridization
the kinetics of hybridization was examined by measuring the energy transfer upon formation of the cy3-rna and cy5-Dna complex. a total of 100 µl of 0.2 µm rna and 0.22 µm Dna in 5mm hepes ph 7.5, 5mm Kcl, were mixed with 50 µl of 10% DmsO and incubated for 5 min. hybridization was initiated by adding 50 µl of 200 mm hepes ph 7.5, 400 mm Kcl, 12 mm mgcl 2 . samples were rapidly mixed in a 100-µl capacity submicro fluorometer cell (nsg Precision, inc., Farmingdale, nY) and immediately placed in a shimadzu rF5301Pc spectrofluorophotometer (columbia, mD) for data collection. the decrease in cy3 emission intensity as a result of energy transfer was monitored using excitation and emission wavelengths of 550 nm and 562 nm, respectively. the high control signal (no hybridization) was determined by mixing cy3-rna with free cy5 dye. the temperature of the sample was controlled by a lauda Brinkman ecoline re310 (Westbury, nY) recirculating water bath.
Confirmation of binding
Isothermal titration calorimetry. the binding affinities of compounds to rna were measured by itc or sPr. itc experiments were performed using a VP-itc instrument (microcal, northampton, ma). measurements were conducted at 25 °c in buffer containing 50 mm hepes, 100 mm Kcl, 3 mm mgcl 2 , and 2.5% DmsO (ph 7.5). in a typical itc experiment, 7 µl of a 200 µm ligand solution was injected into the sample cell containing 1.42 ml of a 20 µm rna solution. corresponding control experiments were conducted in which 7 µl of a 200 µm ligand solution was injected into the sample cell containing buffer alone. the duration of and delay between each injection was 14 and 300 sec, respectively. Baseline correction and peak integration were performed using the Origin analysis software supplied with the instrument. the heat associated with each ligand-buffer injection was subtracted from the corresponding heat associated with ligand-rna injection to provide the heat of ligand binding per injection. Data were fitted with a nonlinear least squares equation using a single-site binding model from the Origin for itc software. the heat released ∆Q(i) from the i th injection is given by the following equation:
where the total heat Q(i) of the solution contained in V o , the active cell volume, is determined at the end of the i th injection by
the value of Q can be determined for any designated values of n (stoichiometry), K (binding constant), and ∆h (binding enthalpy). m t is the bulk concentration of macromolecule in V o , and X t is the bulk concentration of ligand.
Surface plasmon resonance. sPr analyses were conducted using a Biacore s51 sPr biosensor (Biacore aB, Uppsala, sweden) at a Biacore contract research Facility. Biotinylated rna was immobilized on streptavidin (sa) sensor chips. this immobilization procedure produced stable biosensor chips that were reused throughout the compound binding evaluation. Yes/ no binding studies were evaluated at two compound concentrations (1 µm and 10 µm). the compounds were prepared in buffer containing 50 mm hepes, 100 mm Kcl, 3 mm mgcl 2 , and 2.5% DmsO (ph 7.5) and simultaneously injected across a chip with and without rna immobilized to determine if nonspecific binding was occurring. a control compound known to bind to the rna was evaluated periodically throughout the screen to monitor the integrity and activity of the immobilized rna. affinity (K D ) values for select compounds were evaluated by injecting a 6-to 8-compound concentration series over the rna and control surfaces. the data were fitted to a one-site binding model using Biacore s51 software.
RESULTS AND DISCUSSION
SCAN  assay development
Fret-based scan  uses Dna oligonucleotide hybridization to the target rna for detecting small molecule binding (see Fig. 1A ). ligand-rna binding is measured by monitoring the extent of energy transfer between the donor-labeled rna and acceptor-labeled Dna oligo, of a complementary sequence, by competitive binding of the small molecule and Dna to the target rna. assay conditions were chosen to favor stabilization 
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DNA Oligo B of the native rna conformation. Under these conditions, the compound is predicted to bind rapidly to the folded rna whereas rna-Dna hybridization is a much slower process.
several acceptor-labeled Dna capture oligos were chosen for the initial characterization of hybridization to the donorlabeled rna target. the oligos varied in length from 11 to 19 nucleotides and formed perfectly matched Watson-crick base pairs to the rna stem or the stem and loop regions. hybridization to the rna was most extensive for the longer oligos that were complementary to both the full stem and loop regions as assayed by gel shift analysis (data not shown). the oligo chosen for further assay development was designed to hybridize to the entire hairpin stem-loop of hcV ires loop iiid to ensure detection of compounds that bind to the highly conserved loop region (see Fig. 1B) .
the affinity of the Dna oligo for the rna was determined by monitoring the cy3-rna quenching because of energy transfer. the rna was maintained at a constant low concentration while varying the cy5-labeled Dna oligo concentration. as shown in Figure 2 , the rna-Dna hybrid was determined to bind with 1:1 stoichiometry and with very tight affinity (low nanomolar or tighter) similar to what has been reported in the literature for complementary rna-Dna hybrids. 31, 32 the high affinity between the rna and Dna molecules generated a complex that was essentially irreversible as illustrated in the Figure 1A schematic. this tight interaction prevented detecting small molecule binding to the rna with micromolar affinity making an equilibrium assay format impractical for screening and identifying small molecule starting points. altering the Dna oligo sequence (e.g., incorporating base mismatches) for decreasing the rna/Dna hybrid affinity proved to be difficult to predict and consequently a time-consuming approach for assay optimization.
as illustrated in Figure 1A , the hybridization reaction is second order and dependent on the oligonucleotide concentration. altering the oligo concentration provided a way to control the rate of hybridization and the opportunity to format scan  as a kinetic rather than equilibrium assay. the kinetics of hybridization was evaluated at a single wavelength in a spectrofluorophotometer by monitoring the change in cy3-rna emission intensity because of energy transfer. hybridization was initiated by adding a highconcentration salt/buffer mixture (50 mm hepes, 100 mm Kcl, and 3 mm mgcl 2 ) to a premixed solution of the labeled rna and Dna at low salt/buffer concentrations (5 mm hepes and 5 mm Kcl). as expected, the rate of hybridization was dependent on Dna oligo concentration (data not shown). low concentrations of the Dna oligo resulted in slow hybridization kinetics with an observed rate of 0.03 min -1 (see Fig. 3 ) providing a reasonable time frame for high-throughput data collection. a slight excess (1.1×) of Dna to rna was chosen for the standard assay conditions to drive the hybridization reaction to completion and ensure full quenching. When the rna and Dna capture oligo were mixed at low buffer and salt concentrations, no hybridization was observed for at least 24 h; however, it was important for this mixture to have some buffering capacity to ensure that the rna was in its native conformation. Both our own enzymatic digestion studies (data not shown) and nmr solution structures determined at low buffer concentrations, and in the absence of electrolytes, 19 indicate that the rna fragment comprising only the iiid subdomain adopts the same conformation as found in the full-length ires rna.
these studies demonstrated that scan  could be developed as a kinetic based assay to circumvent challenges associated with an equilibrium format using a capture oligo of very high affinity. the standard assay format included mixing 4× compound and buffer/salt solutions. this mixture was added to a 2× rna-Dna solution (with 1.1× Dna) in low salt to initiate hybridization (see materials and methods section for concentration details). a single endpoint read was collected at a time when the hybridization reaction was ~75% complete (45 min). this provided both maximal sensitivity for detecting small molecule binding to rna and inhibition of Dna oligo hybridization, as well as a reasonable assay read time.
Assay validation
screening of a small focused library of 62 compounds, designed to bind rna targets, was executed to assess the robustness of the assay format. the focused library in this study contained proprietary small molecule compounds that were synthesized in-house; no commercially available compounds such as aminoglycosides or peptides were included. cy3/cy5 Fret emission data were collected for both a single-compound concentration and a full-compound dose response at two different time points (45 min and 24 h) for all 62 compounds. the 24-h time point rather than longer times was chosen because a shift in ec 50 values for true binders was detected, there was limited evaporation of the solution from the plate, and this minimized the possibility of rna degradation. rna from the assay plates was collected after the screen and the lack of degradation was confirmed by Page analysis. Figure 4A gives a representative example of a scan  dose response for a positive hit, shown as the %inhibition of rna-Dna hybridization. the %inhibition is calculated from the ratio of the cy3/cy5 Fret emission signal as described in the materials and methods section. Both an increase in the scan  ec 50 (0.4 to 2. Time, s displaced 1 . the itc binding titration for this compound is shown in Figure 4B . the data were fitted to a single bindingsite model and gave a dissociation constant (K D ) of 0.7 µm and a stoichiometry for the binding reaction of 1:1. a total of 26 hits were identified of the 62 compounds screened that prevented rna-Dna hybridization. Of the 26 hits, one false positive was confirmed because of optical interference (e.g., fluorophore). this false positive was readily identified because the dose response was invariant with time (e.g., neither the ec 50 value nor amplitude changed with time as with true binders). a random sampling of 16 compounds of the 26 positive hits were evaluated by itc to determine whether they bound to loop iiid rna. all 16 compounds were confirmed to bind. interestingly, 13 of the 16 compounds evaluated by itc were determined to bind with 1:1 stoichiometry to the rna molecule (see Fig. 4B for an example), suggesting that these compounds are binding to a specific site on the rna. screening of hcV ires loop iiid with our "rna-focused" library resulted is a respectable hit rate of ~40% (25 hits of 62 compounds screened), which is in contrast to what has been reported for other rna targets screened against rna-specific libraries. 33 this implies that one can use a medicinal chemistry approach to generate compounds for rna targets.
the non-hits in this screen fell into two categories, compounds that gave no dose response or no signal, and compounds that gave a negative %inhibition. there were 21 compounds from the focused screen that gave no dose response indicating that they were not hits and therefore were not expected to bind to the rna and inhibit rna-Dna hybridization. ten of these non-hit compounds were evaluated by itc to provide an estimate of the rate of false negatives. no binding was detected for these compounds, demonstrating that no false negatives were identified in this random sampling. it should be noted that one of the 26 hits mentioned above gave a classical dose response at low compound concentrations; however, increased concentrations resulted in a decreased %inhibition possibly because of compound interference or precipitation of assay reagents. if this compound had been screened only at a single concentration, as is typical in a highthroughput screen, it would have been missed, that is, a false negative.
the non-hit compounds that gave a negative %inhibition were predominately caused by an optical interference or selective quenching of one of the fluorophores. this interference caused an artifact in the cy3/cy5 Fret ratio resulting in the calculation of a negative %inhibition. again this optical interference was readily identified by the lack of ec 50 and 1 it cannot be concluded from the data whether the compound must first dissociate from the rna before the Dna oligo can bind or if rna-Dna hybridization occurs through a strand invasion mechanism. amplitude signal change with time or by evaluating the raw data for quenching effects of the signal intensity.
screening of the focused library demonstrated that clean, reliable results were obtained with a very low rate of false positives or negatives being identified. an average Z′ factor of >0.8 was observed allowing for a low percent-inhibition cutoff to be used-a critical assay feature for identifying weak interactions with the target rna. in addition, several compounds were identified that bound specifically to loop iiid with 1:1 stoichiometry and low micromolar affinity that were utilized for further assay optimization.
Screening of Anadys' compound library
the scan  assay was adapted to a high-throughput screening format using a customized automated robotic system for liquid dispensing and Victor V plate readers for endpoint reads. a pilot screen (~4000 compounds) of anadys' compound library was conducted in duplicate to evaluate the robustness of the highthroughput assay. to monitor the assay quality, two columns on each plate were used for the high and low controls. in addition, a tool compound identified from the focused screen was added onto the plates to further assess the quality of the screen. compounds were screened at a final concentration of 25 µm. an endpoint read was collected after incubation for 45 min. as shown by the scatter plot in Figure 5A , good correlation was observed for the two validation sets from the 4000 compound pilot screen. an average Z′ factor of >0.80 was determined for the controls in the validation sets. these results demonstrated the excellent quality of the assay and its suitability for high-throughput screening.
With the optimized assay, ~135,000 small molecule compounds from anadys' library were screened at a concentration of 25 µm. the Z′ was >0.8 throughout the entire screen indicating that the screen was robust and had performed as predicted based on the validation experiments (see Fig. 5B ). a frequency distribution plot of the percent inhibition for each compound shows a typical distribution around zero percent inhibition. Using a >15% inhibition threshold, the majority of hits were distributed around 15% to 20% inhibition (Fig. 5C) . a significant number of hits with 95% to 100% inhibition were also detected; however, these compounds were mostly fluorophores (i.e., false positives) and were readily eliminated upon further hit confirmation. the results from screening the ~135,000 compound library with the scan  assay are summarized in Table 1 .
Using a >15% inhibition cutoff, a total of 826 hits were detected in the primary screen, of which 291 were confirmed upon triplicate repeat testing at 25 µm using a pass criteria of two of three repeats. this represented an initial hit rate of 0.62% and a repeat rate of ~35%. the hit rate and triplicate repeat confirmations observed for this screen were similar to those predicted by the pre-high-throughput screening validation studies. this suggests that the experiments described to validate the high-throughput assay were appropriate and that no unexpected artifacts were identified during the screen. all 291 compounds were evaluated in 11-point doseresponse follow-up studies conducted in triplicate. Data were collected at two time points (45 min and 24 h) to determine the time dependence of the dose response. compounds were eliminated from further consideration if they caused an optical interference (fluorophores or quenchers), exhibited no timedependent dose response, or contained a chemically reactive moiety. Following a review of the scan  ec 50 curves and compound structures, 18 compounds that passed quality-control analysis were selected for further evaluation in secondary assays. none of the 18 screening hits fell into the class of nonselective compounds such as aminoglycosides or peptides. in addition, the hits were not classic polycationic compounds; ~60% of the compounds were uncharged at neutral ph (7.5), whereas the remaining 40% had a net charge of +1.
compounds were evaluated for binding to the loop iiid rna target by either itc or Biacore analysis. For a more thorough analysis of the screening results, a total of 37 compounds were tested including compounds that were and were not expected to bind to loop iiid. Of the 291 compounds evaluated by dose-response follow-up studies, 19 compounds were randomly chosen that gave no dose response or exhibited no change in ec 50 value with time and consequently were not expected to bind. it was confirmed that none of these 19 compounds bound to loop iiid by Biacore (i.e., no false negatives were identified in this subset of compounds). Of the 18 compounds that showed a time-dependent dose response, 12 were confirmed to bind to loop iiid by Biacore, demonstrating that the steps established to evaluate compounds by the scan  assay provided a good prediction of true binders. a plot of scan  ec 50 versus K D for hits identified from screening the 135,000 compound library and the focused screen is shown in 5. (A) correlation plot for the two pilot screen validation sets. an average Z′ factor of >0.80 was calculated for the controls in the pilot screen indicating a robust assay. (B) representative Z′ factor calculated for the controls from the high-throughput screen of the 135,000 compound library from one day of the screening campaign. an average Z′ factor of >0.80 was calculated for the entire screen. (C) Distribution of chemical compound screening data. a total of ~135,000 compounds were screened at 25 µm, using a 384-well format. the high control is the fluorescence resonance energy transfer-labeled rna-Dna reaction mixture in the absence of compound whereas the low control has replaced the cy5-labeled Dna oligo with free cy5 dye, also in the absence of compound. the initial hit rate was 0.62%. Figure 6 and demonstrates that the values determined from independent measurements are highly correlated. these results are suggestive of the ability to use scan  ec 50 values to drive structure-activity relationships (sar) and optimization of compounds by medicinal chemistry.
FIG.
Selectivity screening
it was anticipated that the number of hits identified from a screen would be low; therefore, selectivity screens were designed and performed as secondary assays. the selectivity of identified hits was evaluated by incorporating nonspecific rna, such as trna, into the scan  dose-response analysis. trna was chosen because it is a structured rna molecule that is present in high concentrations in the cell. compound binding to loop iiid rna was evaluated in the presence of increasing concentrations of trna relative to the target rna. Figure 7A shows the effect of adding 0-to 30-fold molar excess trna on the compound dose response (0 µm to 25 µm) for a confirmed hit. evaluating the molar excess alone is an underestimate of the potential binding sites because trna consists of ~3× the number of nucleotides than loop iiid. the ec 50 value was unchanged in the presence of 30-fold molar excess of trna over target rna concentration indicating that the compound bound preferentially to loop iiid. Direct binding (itc) experiments were evaluated to further characterize the interaction of the compound with either loop iiid or trna. as shown in Figure 4B , the confirmed hit binds with 1:1 stoichiometry to loop iiid with an affinity of 0.7 µm. in contrast, binding to trna was nonspecific with no apparent saturation of the binding interaction ( Fig. 8) . these results support the scan  observations that the compound binds with greater specificity to loop iiid. For comparison, the aminoglycoside sisomicin, known to bind promiscuously to rna, was evaluated in the scan  assay in the presence of increasing concentrations of trna (Fig. 7B) . addition of 30-fold molar excess trna FIG. 6. comparison of scan  ec 50 versus K D . K D values were determined either by itc or Biacore. the strong correlation between the two methods (R 2 = 0.72) suggests the ability to use the scan  ec 50 values to drive sar and compound optimization. scan  , Screen for Compounds with Affinity for Nucleic acids; itc, isothermal titration calorimetry. [Sisomicin], µM B resulted in an increased ec 50 value for sisomicin from 1.6 ± 0.2 µm to 4.4 ± 0.8 µm. these results suggest that sisomicin binds loop iiid but with less specificity because the free compound concentration is reduced by nonspecific binding to trna. the data support that addition of trna to the scan  compound dose response as a secondary assay provides the ability to determine whether compounds bind with greater specificity to the target rna.
CONCLUSIONS
a novel optical-based high-throughput screening technology was developed for the detection of small molecules binding to hcV ires loop iiid rna. the screening results demonstrated that a high quality and highly reproducible assay was formatted.
an average Z′ factor of >0.8 was observed allowing for a low percent-inhibition cutoff to be used enabling the identification of low-affinity interactions with the target rna. the cutoffs for the hits from the primary screen and triplicate repeat were set so as to identify as many potential hits as possible. this did lead to a higher false positive hit rate; however, the secondary screens were quite effective at identifying the true hits. We were willing to evaluate a larger set of compounds in the secondary assay at the expense of missing a potential hit. the optimized scan  assay was formatted as an inexpensive, fully automated technology and was employed in a high-throughput screen of ~135,000 compounds. hit follow-up demonstrated a strong correlation between scan  ec 50 and K D values suggesting the potential to use the assay to drive compound optimization.
FIG. 8. itc of compound binding to trna. titration of compound into trna demonstrates that the binding interaction is nonspecific with no apparent saturation of the binding sites. the itc solution conditions are the same as for the scan  assay. the integrated heats have already been corrected for compound titrated into buffer. itc, isothermal titration calorimetry; scan  , Screen for Compounds with Affinity for Nucleic acids. 
